Detalles de la búsqueda
1.
Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer.
J Urol;
: 101097JU0000000000004010, 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758680
2.
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT.
Eur J Nucl Med Mol Imaging;
51(3): 841-851, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37947848
3.
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis.
Eur J Nucl Med Mol Imaging;
2024 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38940843
4.
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.
Radiology;
308(1): e222148, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432081
5.
Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy.
Eur J Nucl Med Mol Imaging;
50(7): 2196-2209, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36859618
6.
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
Eur J Nucl Med Mol Imaging;
50(5): 1466-1486, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36604326
7.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging;
50(9): 2830-2845, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246997
8.
Bone Metastases in Patients with Pancreatic NETs: Prevalence and Prognosis.
Horm Metab Res;
55(12): 827-834, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37611636
9.
[18F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?
Eur Radiol;
33(11): 8366-8375, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338559
10.
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI.
Eur Radiol;
2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38038758
11.
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study.
Q J Nucl Med Mol Imaging;
67(1): 57-68, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309334
12.
First experiences with dynamic renal [68Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate.
Eur J Nucl Med Mol Imaging;
49(10): 3373-3386, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35412053
13.
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.
Eur J Nucl Med Mol Imaging;
49(12): 4271-4281, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35767071
14.
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.
Eur J Nucl Med Mol Imaging;
49(3): 992-1001, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476552
15.
Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system.
BMC Cancer;
22(1): 899, 2022 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35978274
16.
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Lancet Oncol;
22(8): 1115-1125, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34246328
17.
Prostate-specific Membrane Antigen PET in Prostate Cancer.
Radiology;
299(2): 248-260, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33787338
18.
Value of PET imaging for radiation therapy.
Strahlenther Onkol;
197(9): 1-23, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34259912
19.
Just another "Clever Hans"? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer.
Eur J Nucl Med Mol Imaging;
48(10): 3141-3150, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33674891
20.
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis.
Eur J Nucl Med Mol Imaging;
48(4): 1200-1210, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970216